NEW ORLEANS—Men are less likely than women to receive medical therapy for overactive bladder (OAB), researchers reported at the 2015 American Urological Association annual meeting.
In a study of 46,648 patients diagnosed with OAB—including 35,315 women and 11,333 men—Howard Goldman, MD, of Cleveland Clinic, and colleagues found that 33.8% of women received an anticholinergic compared with 19.4% of men. In addition, results showed that men were more likely than women to undergo measurements of postvoid residual urine (31.6% vs. 21.7%) and a diagnostic cystoscopy (9.6% vs. 6.8%), whereas women were more likely to undergo urodynamic testing (6.9% vs. 3.3%).
The investigators noted that despite the large socioeconomic burden of OAB symptoms in the United States, most data in the literature about outcomes and patterns of care are limited to clinical trials and clinical series. Dr. Goldman’s group examined national practice patterns for incident OAB using a national observational dataset (The Humedica electronic health records database).